Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.
about
Complex karyotype, older age, and reduced first-line dose intensity determine poor survival in core binding factor acute myeloid leukemia patients with long-term follow-up.Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.Core-binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy.Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research studyBortezomib interferes with C-KIT processing and transforms the t(8;21)-generated fusion proteins into tumor-suppressing fragments in leukemia cells.Therapy of core binding factor acute myeloid leukemia: incremental improvements toward better long-term results.Are there any new insights for G-CSF and/or AMD3100 in chemotherapy of haematological malignants?Effect of allogeneic hematopoietic stem cell transplantation from matched siblings or unrelated donors during the first complete remission in patients with cytogenetically normal acute myeloid leukemia.Acute myeloid leukemia with the t(8;21) translocation: clinical consequences and biological implications.Evaluation of a disease risk index for adult patients undergoing umbilical cord blood transplantation for haematological malignancies.Prospective randomization of post-remission therapy comparing autologous peripheral blood stem cell transplantation versus high-dose cytarabine consolidation for acute myelogenous leukemia in first remission.Long-term outcomes of allogeneic hematopoietic cell transplantation with intensified myeloablative conditioning for refractory myeloid malignancy.BAALC and WT1 expressions from diagnosis to hematopoietic stem cell transplantation: consecutive monitoring in adult patients with core-binding-factor-positive AML.Old and new prognostic factors in acute myeloid leukemia with deranged core-binding factor beta.Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.Allogeneic stem cell transplant may improve the outcome of adult patients with inv(16) acute myeloid leukemia in first complete remission with poor molecular responses to chemotherapy.Monitoring of post-transplant CBFB-MYH11 as minimal residual disease, rather than KIT mutations, can predict relapse after allogeneic haematopoietic cell transplantation in adults with inv(16) acute myeloid leukaemia.Acute myeloid leukemia
P2860
Q33421005-9BAFF0AB-3911-4D08-8AE4-340CBA9BFE22Q34255090-DCA9C18E-3B0D-43ED-917B-C7C165029C48Q34663691-1567BC74-7689-49CD-A40E-6E99864DF9F5Q35574597-130F1212-525C-426C-A4D3-A4088020AEA4Q35786902-1A3A58E4-007D-4250-A8D4-E7DB87B90E1CQ37372832-466EBEF3-44BC-4DD7-B5F8-0EA491F4DACFQ38622918-9AC27A14-8A84-40E3-A9A1-FADDE6E5EA25Q39805868-0E1DA1D7-4554-4339-8FA7-4270DA23E91FQ41973082-925021D9-3F73-4A4F-B208-56A52D01DA32Q48162997-2EECA2CE-B3CE-4EF5-915F-D1B3CFB9377CQ49833698-F878F43A-B19D-4E6A-8034-31FD7E63EF5DQ50260074-3D73A35C-5E47-4633-A17F-DAC13FCFC2B0Q50995430-21640783-5F84-4799-BA61-8028D96BA3B0Q51039848-F683CE06-271A-4305-A9F2-25D1890BB28BQ53245841-39AE5B48-493A-4487-8DE5-7DE33B6C9F87Q54282566-E2E5442A-1C7B-486D-8348-48D5082342DEQ55015954-8BA283AA-E565-4041-AB0F-279ED1E157EEQ58481761-91850CE9-16A0-4575-B70E-CD16AECA2DB1
P2860
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t(8;21) and inv(16) represent different clinical outcomes.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t
@nl
Hematopoietic stem cell transp ...... t different clinical outcomes.
@en
type
label
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t
@nl
Hematopoietic stem cell transp ...... t different clinical outcomes.
@en
prefLabel
Hematopoietic stem cell transplantation for core binding factor acute myeloid leukemia: t
@nl
Hematopoietic stem cell transp ...... t different clinical outcomes.
@en
P2093
P1433
P1476
Hematopoietic stem cell transp ...... nt different clinical outcomes
@en
P2093
Atsuo Maruta
Hiroyasu Ogawa
Hisashi Sakamaki
Kazuhiro Yago
Koichi Miyamura
Kyuhei Koda
Masaharu Kasai
Ryuji Tanosaki
Satoshi Takahashi
Takashi Yoshida
P304
P356
10.1182/BLOOD-2008-03-145862
P407
P50
P577
2009-01-06T00:00:00Z